NanoTemper Technologies was awarded with the “Deutscher Gründerpreis 2014”, an award for german companies with an extraordinary growth rate and the potential to become a market leader.
NanoTemper Technologies was founded in 2008 and by now is a globally operating high-tech company that develops, produces and markets solutions for biomolecular analytics. NanoTemper’s proprietary technology allows identifying and developing new drug candidates and enables our customers to test the drugs’ potency quickly and effectively.
The founders of NanoTemper Technologies, Dr. Philipp Baaske and Dr. Stefan Duhr, managed to transfer the results of their scientific basic research at the LMU in Munich into a successful business offering a unique and innovative technology to scientists in pharmaceutical or biotech industries as well as in an academic research setting. NanoTemper’s high precision instruments made in Germany are used by thousands of scientists in more than 30 different countries thus paving the way into the premier league of biotech companies.
The “Deutscher Gründerpreis” is the most important award for outstanding entrepreneurs in Germany. Since 2002, this award annually honors innovative and successful companies and thus encourages formation of new companies.